Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
Expected outcomes based on trial data: Average weight loss of 24.2% at 48 weeks (phase 2) Average weight loss of 28.7% at 68 weeks (phase 3, TRIUMPH-4) 100% of participants achieved 5% or greater weight loss 93% achieved 10% or greater 83% achieved 15% or greater Moderate weight loss protocol (8mg target) For researchers who want significant weight loss but have a lower tolerance for side effects, stopping the escalation at 8mg is a validated approach
Mazdutide 9 mg is specifically developed to meet the weight loss needs of people with moderate to severe obesity with a BMI above 30 kg/m 2 in China
Talk to your doctor: Stay connected with your doctor while taking a GLP-1 medication
Caveat: your body may also start shedding flab during this medication plan
Medical societies, including the American Medical Association, have formally acknowledged that BMI is an imperfect measure of adiposity and metabolic health
US$ 20.11
US$ 25.47
US$ 20.38
US$ 23.63
US$ 26.82
US$ 28.92
